Active, not recruitingNCT01623076
The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
Studying Neuromyelitis optica spectrum disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Texas Southwestern Medical Center
- Principal Investigator
- Benjamin M Greenberg, MDUniversity of Texas Southwestern Medical Center
- Enrollment
- 150 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2012 – 2030
Study locations (1)
- The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01623076 on ClinicalTrials.govOther trials for Neuromyelitis optica spectrum disorder
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07377305Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)Tang-Du Hospital
- RECRUITINGNCT05891379Inebilizumab in Acute Neuromyelitis Optica Spectrum DisordersXuanwu Hospital, Beijing
- RECRUITINGNCT05004493Biorepository and Registry for Plasma Exchange PatientsCharles M Knudson
- RECRUITINGNCT04106830Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)Beijing Tiantan Hospital